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Abstract
Background: DNA copy number alterations are one of the main characteristics of the cancer cell
karyotype and can contribute to the complex phenotype of these cells. These alterations can lead
to gains in cellular oncogenes as well as losses in tumor suppressor genes and can span small
intervals as well as involve entire chromosomes. The ability to accurately detect these changes is
central to understanding how they impact the biology of the cell.
Results: We describe a novel algorithm called CARAT (Copy Number Analysis with Regression
And Tree) that uses probe intensity information to infer copy number in an allele-specific manner
from high density DNA oligonuceotide arrays designed to genotype over 100, 000 SNPs. Total and
allele-specific copy number estimations using CARAT are independently evaluated for a subset of
SNPs using quantitative PCR and allelic TaqMan reactions with several human breast cancer cell
lines. The sensitivity and specificity of the algorithm are characterized using DNA samples
containing differing numbers of X chromosomes as well as a test set of normal individuals. Results
from the algorithm show a high degree of agreement with results from independent verification
methods.
Conclusion: Overall, CARAT automatically detects regions with copy number variations and
assigns a significance score to each alteration as well as generating allele-specific output. When
coupled with SNP genotype calls from the same array, CARAT provides additional detail into the
structure of genome wide alterations that can contribute to allelic imbalance.
Background
The cancer cell karyotype is often complex and can
include a range of molecular alterations that span muta-
tions at the single nucleotide level to extensive rearrange-
ments involving whole chromosomes. The activation of
oncogenes as the result of DNA amplifications and the
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inactivation of tumor suppressor genes as the result of
DNA deletions can both contribute to the cancer cell phe-
notype. With the recent identification of large scale copy
number polymorphisms (CNPs) in the human genome as
well, it is increasingly clear that a detailed understanding
of the role of genomic alterations and structure will be
important in the context of both the normal and disease
state [1-8]. Over the years many experimental approaches
have been described that have increased our knowledge of
the cancer genome. These include genome-wide
approaches such as array comparative genomic hybridiza-
tion (array CGH) to cDNA clones [9,10], bacterial artifi-
cial chromosomes (BACs), P1 artificial chromosomes
(PACs) [11,12], and long oligonucleotides [13-15],
restriction landmark genome scanning (RLGS) [16], spec-
tral karyotyping (SKY) [17], molecular subtraction such as
RDA [18], digital karyotyping [19,20], and end sequence
profiling (ESP) [21] as well as more focused approaches
such as high-throughput quantitative PCR (QPCR) and
fluorescence in situ hybridization (FISH) [22]. While no
single experimental approach allows the comprehensive
analysis of all types of chromosomal aberrations, array-
based approaches offer the greatest potential for high res-
olution genome-wide scans.
High density DNA oligonucleotide arrays using light-
directed parallel chemical synthesis allow unprecedented
levels of genetic information to be captured in single
experiments [23-25]. The completion of the human
genome sequence, coupled with the emergence of single
nucleotide polymorphisms (SNPs) as the most common
form of genetic variation among individuals, has led to a
variety of applications for high density genotyping arrays.
In the past, these arrays have been used in traditional loss
of heterozygosity (LOH) analysis using standard
approaches of multiplex PCR for DNA target generation
[26-28]. More recently, a DNA target generation method
using complexity reduction by single primer PCR, termed
whole genome sampling assay (WGSA), was developed
for simultaneous genotyping of over 10, 000 SNPs on a
single array [29,30]. This array has been used for hierar-
chical tumor clustering based on LOH patterns with
human lung cancer cell lines [31], the characterization of
LOH progression in samples from children with acute
lymphoblastic leukemia who relapse after chemotherapy
[32], and for a case-control study of esophageal squamous
cell carcinoma (ESCC) [33]. Furthermore, the array has
also been shown to accurately detect genome-wide DNA
copy number changes [34-36]. By coupling SNP geno-
types with copy number information, detailed insight
into genomic structure can be gleaned. For example,
genomic regions displaying LOH can be differentiated
into regions with hemizygous deletions and regions with
no change in copy number, i.e. copy neutral events, and
genomic regions undergoing copy number loss without
LOH can also be detected [34,37,38]. Allelic imbalance, of
which LOH is one example, can also occur when one
allele is preferentially amplified relative to the other allele.
The coupling of genotypic information with copy number
information from a single array allows genome-wide
allele-typing to be carried out [37,39,40]. This type of
combined analysis can not be made using approaches
such as array CGH (reviewed in [41]) and thus under-
scores the potential power of identifying novel genomic
alterations using high density SNP genotyping arrays.
Recently, the WGSA assay has been extended to allow
highly accurate SNP genotyping of over 100,000 SNPs
from two arrays [42]. With an average inter-marker dis-
tance of 23.6 kb, the arrays provide dense enough cover-
age to enable whole-genome association studies [43]. In
this report we describe a novel algorithm termed CARAT
(Copy Number Analysis with Regression And Tree) that
uses probe intensity information from the GeneChip®
Mapping 100 K set for genome-wide allele-specific copy
number estimations. CARAT is predicated on the use of
the highly accurate genotypes derived from the array to
evaluate allelic dose responses on a SNP-by-SNP basis,
thereby allowing the copy number output for each allele
to be determined. We show using DNA samples from
established cell lines that different types of genetic altera-
tions (amplifications, deletions, and LOH) are readily
detectable using an allele-specific copy number approach.
Thus the coupling of SNP genotypes with allele-specific
copy number information may provide new insight into
complex genomic alterations, such as regions undergoing
allelic imbalance due to differential allelic amplification.
Results and discussion
We have previously described the use of the 10 K SNP gen-
otyping array for chromosomal copy number analysis
[34,35]. Recently, the ability to genotype 100 K SNPs on a
set of arrays has become available and these arrays have
been used for high resolution copy number analysis [44].
As with the 10 K array, the 100 K array set uses the WGSA
target preparation scheme in which single primer PCR
amplification of specific fractions of the genome is carried
out. The primary difference with the 100 K WGSA method
is the use of two separate restriction enzymes that each
generates a higher complexity fraction estimated to be
~300 Mb. In this report we describe a new algorithm
called CARAT. In CARAT, a complex normalization
scheme that incorporates both restriction fragment and
probe sequence information is applied on individual
arrays to reduce any systematic error and to increase com-
parability across experiments. Probes for each SNP are
tested for the ability to support an allelic dosage response
using a set of normal individuals in which the 'AA', 'AB',
and 'BB' genotypes intrinsically represent zero, one, and
two copies of the 'B' allele and two, one, and zero copiesBMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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of the 'A' allele. Probes displaying a strong dosage
response are employed in a regression framework to esti-
mate allele-specific copy number. For any target sample,
the sum of the copy number estimates from the two alleles
is compared against the reference set to derive a signifi-
cance measure of the deviation from the diploid state.
Smoothing is used on the estimated copy number and its
corresponding significance to further reduce the experi-
mental and technical noise. Regression trees [45] are
applied on the smoothed result to partition the genome
into regions with different copy numbers and to assign an
overall significance to such changes.
WGSA 100 K arrays perform robustly for SNP genotyping,
with call rates, reproducibility, and accuracy greater than
99%, 99.7%, and 99.7% respectively [42]. Since CARAT
does rely on genotype calls, any SNPs with systematic
errors in the calls could potentially bias the results. In
order to prevent any such bias, only genotypes with strin-
gent confidence rank scores are used, and SNPs that do
not meet this criterion are scored as "no calls". Although
the majority of steps in CARAT do not make use of "no
call" SNPs, there are several steps that do use them, in
which case they are always compared against all geno-
types to reduce any systematic bias in the analysis.
Among the full complement of over 116 K SNPs, 91,908
(79.1%) display a high allelic dose response as defined by
a linear correlation greater than 0.8 between the target
concentration and chip intensity. Among these SNPs,
51097 (55.6%) incorporated information from all 20 per-
fect match (PM) probes (10 PM 'A' allele (PMa) and 10
PM 'B' allele (PMb)), 31857 (34.6%) incorporated infor-
mation from 15 ~ 19 probes, 8268 (8.9%) incorporated
information from 10 ~ 14 probes, 682 (0.74%) incorpo-
rated information from 5 ~ 9 probes, 4 (0.004%) incorpo-
rated information from 3 or 4 out of 20 probes, and no
SNPs used less than 3 probes. This subset of 91, 908 SNPs,
with an average inter-marker distance of 30.5 kb, was used
in CARAT for copy number estimations.
Panels a-d show the standardized ln(PMa) + ln(PMb) intensity for the 1X, 3X, 4X, and 5X DNA samples relative to the intensity  of the 2X DNA sample Figure 1
Panels a-d show the standardized ln(PMa) + ln(PMb) intensity for the 1X, 3X, 4X, and 5X DNA samples relative to the intensity 
of the 2X DNA sample. Black data points correspond to autosomal SNPs and red data points correspond to the 1,955 X-chro-
mosome SNPs. The blue line in each panel represents the Y = X line. Panel e shows the relationship between the natural log-
transformed copy number and the natural log-transformed intensity. The x-axis is the natural log-transformed copy number 
and the y axis is the average ln(PMa) + ln(PMb) intensity across 1,955 SNPs. The blue line is the regression using the average 
intensity as the response and the natural log-transformed copy number as the predictor.BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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The performance of CARAT was evaluated with a set of test
samples that included 90 normal individuals, DNA sam-
ples with varying numbers of X chromosomes (1X to 5X),
and several human breast cancer cell lines that harbor
both low level and high level copy number alterations.
None of these test samples have any overlap with the 128
training samples that are used to establish and tune the
CARAT models.
The relationship between DNA copy number and fluores-
cent intensity of the SNP hybridization signal was evalu-
ated using genomic DNA derived from cell lines with a
defined number of X chromosomes (1X to 5X). Among
the 91,908 selected SNPs, 1,955 map to the X chromo-
some. A normal 2X (NA15029) female sample was used
as the reference for comparisons to the 1X, 3X, 4X, and 5X
samples. The results are summarized in Figure 1. Panels a-
d show that there is a high linear correlation among the
sample pairs, and only X-chromosome SNPs (labeled in
red) show intensity profile shifts across the four panels
while the autosomal SNPs (labeled in black) remain
static. Panel e indicates that there is a strong linear rela-
tionship between the log transformed copy number and
the log transformed intensity. These results show that the
100 K WGSA PCR fractions maintain a nice dose response
between the input template copy number and the post
hybridization SNP fluorescent intensity.
Table 1 summarizes the true positive rates for detection of
X chromosome changes using the 1X, 3X, 4X and 5X DNA
samples along with the false positive rate of detection of
autosomal SNPs deviating from the diploid state using the
test set of 90 normal individuals. Values are computed for
all samples at several different stages of CARAT and at var-
ious significance thresholds. The results indicate that the
addition of the kernel smoothing and the tree partitioning
steps improves the true positive rate and decreases the
false positive rate; only at the most stringent significance
cut-off does the false positive rate exceed the expected
value. Moreover, with the regression tree partition func-
tion, CARAT defines the alterations on the X chromosome
as a single region for all four samples with a very high sig-
nificance. The overall copy number estimates (and signif-
icance) for the X chromosome using the 1X to 5X samples
are: 1X:0.92 (1.99 × 10-4), 3X:3.21 (8.13 × 10-6), 4X:4.36
(6.15 × 10-12) and 5X:5.74 (1.50 × 10-16).
These 90 HapMap CEPH samples (30 trios) thus served as
an independent test set to evaluate the accuracy of the SNP
copy number estimations as well as the algorithm's false-
positive rate (FPR). These samples were assumed to repre-
sent normal diploid genomes which do not harbor exten-
sive genomic deletions or amplifications. Although these
samples could contain copy number polymorphisms,
they are relatively rare and were not considered in this
analysis, which potentially could lead to an overestima-
tion of the true false positive rate. There were 89,953 auto-
somal SNPs among the total of 91,908 selected SNPs that
were examined across the 90 individuals for a total of
8,095,770 data points; X chromosome SNPs were
excluded due to copy number differences between males
and females. One possible explanation for the higher-
Table 1: Estimation of true positive and false positive rates under varying significance thresholds using 1X to 5X samples and 90 
normal test samples.
Sample and Data Stage p-value < 10-2 p-value < 10-4 p-value < 10-6 Total
Count Percent Count Percent Count Percent Count
90 normal samples (autosomes) SP 409049 5.05% 42182 0.52% 11154 0.14% 8095770
KS 40247 0.497% 3302 0.041% 770 0.009% 8095770
TR 5417 0.067% 506 0.006% 167 0.002% 8095770
1X SP 1441 73.71% 694 35.50% 286 14.63% 1955
KS 1780 91.05% 714 36.52% 111 5.68% 1955
TR p-value = 1.99 × 10-4 1955
3X SP 1271 65.01% 879 44.96% 603 30.84% 1955
KS 1707 87.31% 1136 58.11% 547 27.98% 1955
TR p-value = 8.13 × 10-6 1955
4X SP 1726 88.29% 1523 77.90% 1343 68.70% 1955
KS 1929 98.67% 1861 95.19% 1697 86.80% 1955
TR p-value = 6.15 × 10-12 1955
5X SP 1884 96.37% 1801 92.12% 1724 88.18% 1955
KS 1950 99.74% 1933 98.87% 1907 97.54% 1955
TR p-value = 1.50 × 10-16 1955
Notes:
1 SP: Single point analysis
2 KS: Kernel smoothing with 100 kb window after single point analysis
3 TR: Tree partitioning of the genome on the kernel smoothed result.BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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than-expected false positive rate at the stringent p-value of
less than 10-6 is that they are not false positives but rather
true and significant copy number polymorphisms occur-
ring in normal people. For example, there were 167 data
points identified with a significance level less than 10-6.
Among them, 72 SNPs were derived from a common
amplified region on chromosome 8 from two samples
originating from the same trio, namely NA12802 (child)
and NA12814 (father), with each sample showing the
same 36 significant SNPs. Although this amplified region
(~16.34–16.85 Mb) has not been independently verified
using QPCR, it does partially overlap with a BAC clone
(RP11-90I3) from 8p22 that has detected a CNP [2] and
thus may represent a CNP that is transmitted through gen-
The upper panel shows the mean autosomal SNP copy number and the associated standard deviation using kernel smoothing  alone and kernel smoothing combined with the tree partition for each of the 90 normal samples in the independent test set Figure 2
The upper panel shows the mean autosomal SNP copy number and the associated standard deviation using kernel smoothing 
alone and kernel smoothing combined with the tree partition for each of the 90 normal samples in the independent test set. 
The solid lines correspond to the mean estimation and the dotted lines represent the mean plus or minus one standard devia-
tion. The lower panel shows the proportion of the genome (autosomal chromosomes only) that is determined to be in the 
normal diploid state for the 90 individuals. The blue colored lines in both panels represent results using kernel smoothing alone 
while the red colored lines represent results from kernel smoothing combined with the regression tree partition.BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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Each panel shows a series of ROC curves derived from different stages of CARAT using samples with X chromosome altera- tions Figure 3
Each panel shows a series of ROC curves derived from different stages of CARAT using samples with X chromosome altera-
tions. Stage 1: Single point analysis that contains no probe selection, no intensity adjustment on fragment length and GC con-
tent; and no intensity adjustment on the reference mean. Stage 2: Stage 1 plus probe selection. Stage 3: Stage 2 plus intensity 
adjustment on the fragment length and GC content and intensity adjustment on the reference mean. Stage 4: Stage 3 plus ker-
nel smoothing with a 100 kb window. Stage 5: Stage 4 plus genome partitioning using the regression tree. This figure should be 
viewed in conjunction with Table 2 which summarizes the area under the ROC curves.BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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erations. The copy number estimation of each autosomal
SNP across these 90 test samples also has relatively low
variation as shown in the upper panel of Figure 2. The
mean copy number estimate across all autosomal SNPs
ranges from 1.951 to 2.032 and is similar whether using
only kernel smoothing or kernel smoothing combined
with regression trees. However, by adding the regression
tree as the final partition step, the standard deviation is
dramatically reduced by an average of 81.4%, and the
range changes from (0.149, 0.367) to (0.019, 0.037). The
lower panel shows the proportion of the genome on a per-
sample basis that does not contain any significant
changes. Using regression trees, there are many more
regions identified as diploid as compared to using kernel
smoothing only, indicating an improvement in the appar-
ent false positive rate.
Receiver Operating Characteristic (ROC) curves were used
to evaluate the overall sensitivity (true positive fraction)
and specificity (true negative fraction) of different stages
of CARAT. The curves are calculated using 1,955 X chro-
mosome SNPs, with the false positive rate estimated by
averaging the individual false positive signals across the
47 female samples present in the total set of 90 normal
individuals. Figure 3 shows the ROC curves derived from
different stages of the algorithm using DNA samples with
differing numbers of X-chromosomes; Table 2 summa-
rizes the area under those curves depicted in Figure 3. The
most significant improvement comes from the adjust-
ment based on fragment length, GC content and reference
mean; the AUC (Area Under the Curve) increases about
50% for the 1X, 3X and 4X samples and 21.5% for the 5X
sample. The improvement from probe-selection is rela-
tively modest, resulting in an overall increase across the
samples of about 5%. Although adding kernel smoothing
in stage 4 and tree partitions in stage 5 does not substan-
tially increase the AUC, these steps are nevertheless criti-
cal. These two steps drive the AUC towards 1, ensuring
high sensitivity while keeping the specificity extremely
low, which is a necessity since nearly 92 K SNPs are simul-
taneously being examined. In the tree partitioning step
(stage 5), the ROC curves are ideal for the 4X and the 5X
samples, rendering an AUC of 1. For the 1X and the 3X
samples, the ROC curves are not smooth but rather step-
functions that achieve a 100% true positive rate with a
minimum false positive rate. This occurs because for each
case the regression tree step successfully identifies the var-
iations on the X chromosome as one altered region and
assigns the region a high significance score that rarely
occurs in normal female samples.
The previous DNA samples with variable X chromosome
content provided a means to evaluate the algorithm using
large alterations that span the length of an entire chromo-
some. In order to better evaluate the performance of
CARAT when the alterations were of low level copy
number changes that did not span entire chromosomes,
as well as evaluating CARAT relative to other methods, a
series of experiments were carried out. These experiments
included QPCR on 69 SNPs chosen from the cancer cell
line SK-BR-3, QPCR around the HER2/neu region using
three cancer cell lines; and allele-specific TaqMan on nine
SNPs across two cell lines coupled with DNA sequence
analysis. All experimental results show a high correlation
with CARAT-derived estimates, indicating that the algo-
rithm in combination with the Mapping 100 K array set
can detect chromosomal copy number changes in an
accurate and quantitative manner.
We used QPCR as an independent method to determine
the total copy number of 69 autosomal SNPs from SK-BR-
3. These results were then compared to copy number out-
put from CARAT and two additional algorithms used for
Mapping 100 K copy number analysis, namely dCHIP
[46] and CNAG [47]. These SNPs are derived from regions
of SK-BR-3 that display copy number gains and losses as
well as regions with no detectable changes, covering 16 of
the 22 autosomes and more than 60 different regions; 10
of the 69 SNPs have a copy number between 1.5 and 2.5,
indicating no major alterations from diploidy; 14 of the
69 SNPs have been excluded from CNAG because the
SNPs reside on restriction fragments shorter than 500 bp
and are resistant to the compensations used in CNAG
(Table 3). Figure 4 summarizes the comparison of the cor-
relations between the copy number derived from the three
algorithms at different stages and the copy number
derived from QPCR. The results show that the correlation
values across the three methods are not significantly dif-
ferent. However, both CNAG and dCHIP under-estimate
the total DNA copy number, although to different extents.
In CNAG, neither the averaging across neighboring points
nor the HMM procedure leads to a significant increase in
the correlation. In contrast, the HMM step in dCHIP and
the kernel smoothing step in CARAT do improve their
respective correlations. In Table 4, the performance of the
three methods is examined by evaluating the sensitivity
and specificity using the same 69 QPCR results. In CNAG,
because the estimation is biased towards the normal dip-
loid state, it achieves perfect specificity while demonstrat-
ing substantially lower sensitivity compared to the other
two methods. Although dCHIP and CARAT have similar
performances with one another, CARAT has a higher sen-
sitivity in the single-point estimation step and the
smoothing step while dCHIP has higher specificity in the
smoothing step. In dCHIP, the averaging and HMM steps
steadily improve both the sensitivity and the specificity
while in CARAT the sensitivity remains the same while the
specificity is substantially increased through the three
stages. Neither dCHIP nor CNAG has a significance meas-
ure associated with the estimated copy number at the sin-BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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gle SNP level. Thus, in an attempt to compare the three
algorithms, only copy number output from CARAT has
been used, rather than the combination of copy number
output and the associated p-values. The only exception to
this is the analysis of the tree partitioning step in which
algorithm-based true negatives are defined as SNPs with
p-value > 0.005 and algorithm-based true positives are
defined as SNPs with p-value < 0.005. Although the p-val-
ues from the regression tree step may not have a direct
probabilistic interpretation, they nonetheless are derived
from individual p-value estimates and thus serve as confi-
dence scores that measures how significantly the region
deviates from the diploid state. The use of a significance
level rather than a copy number value as a threshold to
differentiate altered regions from normal regions is appro-
priate with CARAT, and provides a more accurate estima-
tion of the true performance of CARAT. In this case,
CARAT achieves perfect specificity of one and a very high
specificity resulting in overall superior performance.
Additional verification of DNA copy number changes
detected by CARAT was done using the highly character-
ized region on chromosome 17q12 harboring the ERBB2
(HER2/neu) proto-oncogene that is amplified in nearly
30% of breast cancers [48]. Figure 5 shows a comparison
of chromosome 17 for three human breast cancer cell
lines. The genomic region near HER2/neu appears ampli-
fied in the two cancer cell lines SK-BR-3 (panel a) and ZR-
75-30 (panel e) with moderate to very strong significance
(significance data not shown) and does not appear ampli-
fied in MCF-7 (panel c). This is consistent with published
CGH results that show SK-BR-3 and ZR-75-30, but not
MCF-7, contain gains in 17q12 [49] as well as with
ERBB2-specific FISH showing amplification in SK-BR-3
(45 signals per cell) but not MCF-7 (2.5 signals per cell)
[50]. Quantitative PCR was carried out with a HER2/neu
primer pair and confirmed the copy number increase in
two of the three cell lines (Table 5). The estimated HER2/
neu copy number by QPCR for SK-BR-3, MCF-7, and ZR-
75-30 is 12.4, 0.8, and 27.7 respectively. While the array
set does not contain SNPs within the HER2/neu gene, the
SNPs which flank the locus are SNPs 1720794 and
1738376. CARAT results for these SNPs are also summa-
rized in Table 5 and confirm that the region surrounding
HER2/NEU is amplified in two of the three cell lines. In
Figure 5 all three cell lines show LOH in this region. Based
on CARAT, MCF-7 shows one copy loss at the HER2/neu
locus itself and proximal to the locus while there is no
apparent copy number change distal to the locus. Addi-
tionally, SK-BR-3 and ZR-75-30 both show differential
amplification of one allele relative to the other, resulting
in allelic imbalance. These regions also serve to under-
score how genotypic information can complement copy
number information in the detection of complex struc-
tural alterations in regions exhibiting LOH. In Figure 5
panels b, d and f, results from CARAT are also consistent
with additional regional copy-number increases observed
by CGH using metaphase chromosomes in MCF-7
(17q22-q24; ~47.5–68.4 Mb), SK-BR-3 (17q24-qter;
~59.9––78.8 Mb), and ZR-75-30 (17cen-q24; ~22.8–68.4
Mb) [49].
We chose 9 SNPs distributed across five different chromo-
somes for TaqMan analysis as an independent verification
of allelic copy number information. These SNPs were
identified by CARAT and represent various types of altera-
tions. Allelic copy number results from CARAT and Taq-
Man for these SNPs across two cell lines are summarized
in Table 6. TaqMan reactions for each SNP were done with
genomic DNA from SK-BR-3 and ZR-75-30 as well as with
normal DNA samples representing AA, AB, and BB geno-
types that serve as positive controls for allele dosage.
There are a total of 36 allele-specific copy number esti-
mates when combining results for nine SNPs from the two
Table 2: Area under the ROC curve derived from different stages of the CARAT method.
Area under ROC Curve 1X 3X 4X 5X
Stage 1 0.6240 0.5188 0.6575 0.7863
Stage 2 0.6732 0.5384 0.6840 0.8128
Stage 3 0.9319 0.8987 0.9546 0.9877
Stage 4 0.9887 0.9759 0.9974 0.9995
Stage 5 0.9999 0.9999 1.0000 1.0000
Note:
1The specificity is estimated using the 47 female samples that are a subset of the 90 normal test set samples and is restricted to the 1955 X 
chromosome SNPs. The sensitivity is estimated on 1955 X chromosome SNPs using DNA samples with 1X, 3X, 4X and 5X chromosomes.
2Stage 1: Single point analysis: no probe selection, no intensity adjustment on fragment length and GC content; no intensity adjustment on reference 
mean.
3Stage 2: Stage 1 plus probe selection.
4Stage 3: Stage 2 plus intensity adjustment on the fragment length and GC content and intensity adjustment on the reference mean.
5Stage 4: Stage 3 plus kernel smoothing with a 100 kb window.
6Stage 5: Stage 4 plus genome partitioning using the regression tree.BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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cancer cell lines on both alleles. In general, there is a high
linear correlation between the allelic copy number esti-
mates using the algorithm and the allelic copy number
derived from TaqMan reactions (Cor = 0.87). Among the
36 data points, there are 12 examples with a TaqMan-
determined copy number lower than 0.5 and thus may
indicate the loss of an allele. 10 out of these 12 examples
also show a CARAT copy number estimation lower than
0.5, indicating a strong consistency between the two
methods. These 12 examples can be further separated into
four categories: (1) normal homozygous SNP (one allele
present in two copies, the other allele absent), which
includes SNP 1724728 and SNP 1736669 from ZR-75-30;
(2) homozygous deletion (both alleles absent), which
includes SNP 1670177 from SK-BR-3; (2) hemizygous
deletion (one allele absent, one allele present at one
copy), which includes SNPs 1724728 and 1718017 from
SK-BR-3 and SNPs 1726250, 112706 and 1670177 from
ZR-75-30; (4) hemizgyous deletion and one allele ampli-
fication (one allele absent and the other amplified),
which includes SNP 1700191 from both samples, and
SNP 1693987 from SK-BR-3. There are also 9 examples
with a TaqMan-determined copy number higher than 2.5
indicating putative allelic amplification; all of these 9
examples also have a CARAT copy number estimation
higher than 2.5. Some examples are explained by category
(4) described above, while the remaining examples all
appear as asymmetric amplifications (one allele remains
intact, one allele amplified), including SNPs 1726250,
1746553, 1710029 from SK-BR-3 and SNPs 1710029 and
1718017 from ZR-75-30. When the TaqMan-determined
total copy number is less than 1 or greater than 3, the
Table 3: Detailed information on the 69 SNPs with q-PCR result on SK-BR-3.
ID Chr Pos 2∆Ct + 1 CNAG ID Chr Pos 2∆Ct + 1 CNAG
1715815 1 18690258 3.488 1 1730991 8 12219548 26.909 1
1677772 1 18961201 5.667 1 1736241 8 12247290 25.15 1
1701237 1 18961224 7.26 1 1733286 8 12247313 16.336 1
1754488 1 19467510 3.824 0 1705485 8 12284860 14.52 1
1682316 2 10879223 2.144 1 1642293 8 12466876 15.428 1
1721952 2 11234432 2.54 0 1642509 8 12706003 1.588 1
1685376 3 2910083 2.056 1 1710395 8 12781129 12.376 1
1739241 3 54136934 1.599 1 1756158 8 12793955 14.566 1
1740943 3 17277166 1.464 1 1655411 8 13167929 0.05 1
1724728 4 9565339 1.155 1 1745005 8 13167938 1.079 1
1684152 4 9939264 0.878 1 1688950 8 13935299 1.092 0
1691466 4 18055558 0.961 1 1707862 9 28313673 1.735 1
1750183 4 36828550 1.055 1 1753803 10 93029981 1.253 1
1741115 4 10257358 4.408 0 1662598 10 95045955 0.953 0
1752629 4 10359355 3.122 1 1703209 12 38583007 3.249 0
1688092 4 15453342 2.467 1 1736669 12 41456018 2.01 0
1678384 4 17883743 5.948 1 1704347 13 10715383 3.358 1
1744079 5 15244637 5.483 1 1745652 15 78297093 2.27 1
1720887 7 11014665 3.084 1 1671362 17 10226391 1.27 0
1702115 7 12400720 5.116 1 1682916 17 37814459 29.293 1
1718607 7 12669364 4.571 1 1693987 17 39301708 14.672 1
1757769 8 17939677 1.542 1 1754640 17 40022109 4.865 1
1665304 8 71285928 19.126 1 1757956 17 42235557 1.037 0
1688836 8 75872813 3.289 1 1718017 17 48767363 1.091 1
1751239 8 78708089 4.098 1 1644936 18 5903606 2.003 1
1663022 8 79625135 9.142 0 1731333 18 47360984 0.7 1
1685422 8 87105878 6.207 1 1707435 18 48017003 0.433 1
1684480 8 87106029 6.229 1 1664936 18 48130851 0.476 1
1726250 8 89504951 10.056 1 1666836 18 48130957 0.498 1
1644190 8 90597245 5.169 1 1727821 18 48131045 0.622 1
1666582 8 10542849 0.572 1 1670177 19 20287003 0.227 1
1649454 8 10566581 0.428 0 1679882 19 20533429 0.086 1
1700191 8 11201815 32.706 1 1653046 19 23871401 0.025 0
1746553 8 12034217 13.881 0 1739377 20 10000010 7.198 0
1691086 8 12055400 10.465 1
Note:
12∆Ct + 1: theoretical estimate of total copy number using QPCR
2CNAG: "1" means included in the CNAG analysis (total 55); "0" means excluded from CNAG analysis (total 14) because the SNP resides on a 
restriction fragment of less than 500 bp.BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
Page 10 of 21
(page number not for citation purposes)
These nine panels show comparisons among CARAT, dCHIP and CNAG qPCR results of 69 autosomal SNPs from the human  breast cancer cell line SK-BR-3 Figure 4
These nine panels show comparisons among CARAT, dCHIP and CNAG qPCR results of 69 autosomal SNPs from the human 
breast cancer cell line SK-BR-3. In each scatter plot the x-axis is the copy number derived from QPCR and the y-axis is the 
copy number derived from one of the three algorithms. ∆Ct denotes the difference between the normal DNA sample versus 
SK-BR-3. The threshold cycle (Ct) is the cycle number at which the reporter fluorescence passes a fixed threshold above base-
line. A positive ∆Ct suggests an amplification while a negative ∆Ct suggests a deletion. The copy number of SK-BR-3 based on 
QPCR is inferred as 2(∆Ct + 1). The red points are the 55 SNPs that were included in the CNAG analysis; the black points are 
the 14 additional SNPs that were included in dCHIP and CARAT analysis but were excluded from CNAG. Correlations are 
calculated for each of these two different SNP sets. The blue line in each panel represents the Y = X line. Panels (a), (b), and (c) 
compare single point analysis across the three methods; panels (d), (e), and (f) compare smoothing across neighboring points; 
panels (g), (h), and (i) compare genome partitioning across the three methods.BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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CARAT determined p-value is always very significant (<
0.0001) with a single exception of SNP 112706 from ZR-
75-30 (p-value 0.002).
In addition to allelic TaqMan reactions, direct DNA
sequencing was carried out on PCR amplicons from both
cell lines for seven of the SNPs. Several examples are
shown in Figure 6. Panels a and d represent sequence
traces using a forward primer for SNP 1693987 from SK-
BR-3 and ZR-75-30 respectively. The polymorphic nucle-
otide in the sense strand is either C (allele A) or T (allele
B). SK-BR-3 shows a clear blue peak representing the A
allele while ZR-75-30 shows a clear red peak representing
the B allele. Both of these base calls are consistent with the
predominant allele identified by both CARAT and Taq-
Man. The copy number of allele B (SNP 1693987) from
SK-BR-3 is below 0.5 copies based on CARAT and TaqMan
while the copy number of allele A is greater than six with
both methods. The DNA sequence trace however does not
detect the presence of the minor allele. In contrast, the sig-
nal from the minor allele can be detected in the case of
SNP 1718017 as shown in panels b, c, e, and f. The poly-
morphic nucleotide in the sense strand is either G (allele
A) or T (allele B). Sequence traces using the forward
primer show that in both cell lines the major allele is the
A allele (G) as indicated by the black peak. However, ZR-
75-30 also shows a smaller red peak indicating the pres-
ence of allele B (T). The tracings using the reverse primer
also confirm the major allele is the A allele (G) in both cell
lines, and ZR-75-30 again shows a minor green peak cor-
responding to allele B (T). There is no clear detection of
the minor allele in the sequence traces from SK-BR-3
(panel b and c) which is consistent with both the CARAT
(0.15 copies) and TaqMan (0 copies) results. In ZR-75-30,
the ratio of the A allele peak height to the B allele peak
height is 3.3 in the forward traces and 4.9 in the reverse
traces, which are in general agreement with the allele
ratios of 3.2 by CARAT and 5.0 by TaqMan. Thus the DNA
sequencing results for this SNP confirm the CARAT and
TaqMan results which suggested that allele B was present
Table 4: Comparison among CARAT, dCHIP and CNAG using QPCR results.
Method Stage Sensitivity Specificity
CARAT Single Point 0.956 (0.932) 0.444 (0.4)
100 kb Smoothing 0.957 (0.898) 0.556 (0.6)
Tree Partitioning 0.957 (0.932) 0.778 (0.8)
Tree Partitioning (p-value) 0.957 (0.881) 1 (1)
dCHIP Single Point 0.783 (0.780) 0.333 (0.4)
10 Points Median 0.864 (0.913) 0.7 (0.667)
HMM 0.978 (0.898) 0.778 (0.8)
CNAG Single Point 0.609 1
10 points Mean 0.522 1
HMM 0.717 1
Note: SNPs that have no copy number alterations relative to the diploid state (true negative SNPs) are defined by a QPCR derived copy number 
between 1.5 and 2.5. SNPs that have copy number alterations (true positive SNPs) are defined by a QPCR derived copy number less than 1.5 or 
greater than 2.5. There are in total 10 true negatives among all 69 SNPs. For the 55 SNPs that are common to CNAG, there are 9 true negatives. 
The calculations of sensitivity and specificity compare QPCR values to algorithm outputs in which algorithm-defined true negatives are the SNPs 
with an estimated copy number between 1.5 and 2.5 and algorithm-defined true positives are the SNPs with an estimated copy number less than 1.5 
or greater than 2.5. In the CARAT tree-partitioning (p-value) comparison, the algorithm defined negative SNPs are those with p-value > 0.005 and 
algorithm defined positive SNPs are those with p-value < 0.005. Numerical values without parentheses are derived from comparisons using only the 
55 SNPs that are in common with CNAG while the numbers inside parentheses are derived from comparisons using all 69 SNPs.
Table 5: Comparison of QPCR and CARAT on HER2/neu locus across three cell lines.
HER2/NEU Region on Chr 17
Sample SNP 1720794 12.48 kb proximal HER2/neu 38231.31–
38259.79 kb
SNP 1738376 91.64 kb distal
CARAT p-val 2∆Ct + 1 CARAT p-val
SK-BR-3 19.0 <10-20 12.4 19.0 <10-20
ZR-75-30 25.1 <10-20 27.7 25.1 <10-20
MCF-7 1.0 0.0003 0.8 2.1 0.567
Note:
12∆Ct + 1: theoretical estimate of total copy number using QPCR
2CARAT: copy number estimated by CARAT
3p-val: The statistical significance of the copy number alteration. It is derived from the algorithm by comparing the target sample to a reference set 
consisting of normal individualsBMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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in at least one to two copies in ZR-75-30 but not in SK-BR-
3.
Conclusion
We have developed an algorithm CARAT used in conjunc-
tion with the GeneChip® Mapping 100 K Set that provides
accurate copy number estimates in an allele-specific man-
ner. This algorithm makes use of the highly accurate gen-
otypic information across a set of normal individuals to
identify probes with strong allele-specific dose responses.
The copy number estimation is accompanied by a signifi-
cance score derived by a comparison to a reference set of
normal individuals. Kernel smoothing with a Gaussian
kernel and a relatively small bandwidth of 100kb is
applied on the individual estimates in an attempt to
achieve a balance between resolution and noise reduc-
tion. Regression trees are applied at the final stage as a
method to partition the genome into regions that share
the same copy number and to assign an overall copy
number and significance to every region that alters from
the diploid state. This partitioning step further reduces the
random variability from SNP to SNP and increases the
interpretability of the output. Although regression trees
are conceptually simple, they solve the complex issue of
how to define genomic regions with similar alterations.
The assumption under regression trees is that different
regions of the feature space have a constant outcome.
With a series of recursive binary splits, they efficiently and
accurately stratify the feature space into groups such that
the random deviation from the fitted constant is mini-
Three human breast cancer cell lines are represented by panels a-b (SK-BR-3), panels c-d (MCF-7), and panels e-f (ZR-75-30) Figure 5
Three human breast cancer cell lines are represented by panels a-b (SK-BR-3), panels c-d (MCF-7), and panels e-f (ZR-75-30). 
The X-axis in all six panels is the physical position of SNPs along chromosome 17. The vertical lines just above the X-axis of 
each panel represent heterozygous (green) and homozygous (red) genotype calls. The Y-axis in all six panels is the estimated 
copy number. The points are derived from the kernel smoothing step and the solid horizontal lines are derived from the 
regression tree. Black colored lines indicate total copy number, the blue colored lines indicate the allele with the higher copy 
number estimate and the purple colored lines indicate the allele with the lower copy estimate. The vertical black line proximal 
to 40 Mb indicates the location of the HER2/neu gene. The panels on the left (panels a, c, and e) show an enlarged view of the 
genomic region harboring HER2/neu while the panels on the right (panels b, d, and f) show a larger view of the chromosome.BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
Page 13 of 21
(page number not for citation purposes)
mized [51]. In the application of regression trees to DNA
copy number analysis, the feature space is one dimen-
sional and corresponds to the physical location on the
chromosome while the outcome is the unknown copy
number. The non-parametric nature of the tree method
thus uncouples it from the many assumptions associated
with particular distributions, which is especially appropri-
ate for this array-platform since the behavior of probe
intensity can be complex and difficult to summarize. The
kernel smoothing step used for noise reduction and the
tree partitioning step used for genome segmentation pro-
vide an optimal combination that renders high perform-
ance along with simple interpretation of the output [52].
This combination of information allows genomic altera-
tions that lead to allelic imbalance to be characterized in
a manner that is not currently possible by approaches
such as CGH. Additionally, allelic copy number poten-
tially allows examples of both whole chromosome and
segmental uniparental disomy to be identified as well as
genome-wide assessments of monoallelic amplification
[53].
There are a number of alternative statistical methods that
have been used to analyze array data for the purpose of
copy number variation detection. Several approaches
have used Hidden Markov Models (HMMs) [1,47,54,55].
Although in general the Markov chain framework does fit
genome-wide copy number variation, determination of
the specific parameters in the model can depend on the
patterns of variation in the samples. Thus the performance
hinges on how well the actual distribution of copy
number variation from experimental samples such as can-
cer cells, which is largely unknown, agrees with the distri-
bution hypothesized by the model. In this study we
compared CARAT with two methods that use HMMs,
namely dCHIP and CNAG. The performance between
dCHIP and CARAT is similar, while CNAG tends to bias
towards the normal diploid stage. In addition, dCHIP can
not offer allele specific information in contrast to CARAT
and CNAG. However, the allele specific estimation in
CNAG is only feasible in matched pairs of samples and
then only considers those SNPs that are called hetero-
zygous in the normal matched sample. CARAT is free of
these constraints and allele specific copy number can be
estimated on any SNP with any sample.
Additional approaches include change-point analysis
[56,57] or posterior log likelihood [58] to partition the
genome into normal versus changed regions. These
approaches assume that the intensity variability of probes
corresponding to sub-regions of the genome is similar.
However, using WGSA and the high density arrays, we
observe substantial variation in the intensities of different
SNPs. This can result from differences in SNP probe
sequences as well as the restriction fragment target
sequences. Regression on the probe GC content and the
restriction fragment length stabilizes SNP variability and
improves sample-to-sample comparability. In addition,
the use of a large normal reference set enables the inten-
sity distribution on diploid genomes to be directly esti-
mated at an individual SNP level, thereby improving the
accuracy of the model. There is also an algorithm that uses
a hierarchical clustering scheme along the chromosome to
identify changes. Here the signal threshold is set by
directly controlling the false discovery rate (FDR), provid-
ing researchers with a high level of confidence regarding
their findings [59]. The challenge with such an approach
is that a desirable FDR level can preclude the detection of
moderate changes that only span a short stretch of the
genome. This issue is also relevant to our algorithm in that
the p-value threshold which separates significance from
insignificance is determined empirically with the test set
of normal individuals and with ROC analyses using the
1X to 5X samples; however, there still exists a balance
Table 6: Allele specific Taqman results
Sample SK-BR-3 ZR-75-30
SNPID Chr Pos P-Value CN_A CN_B DM Call P-Value CN_A CN_B DM Call
1724728 4 9565339 0.0001 0.89 (0.85) 0.22 (0.0) AA 0.0006 1.77 (1.5) 0.19 (0.02) NC
1726250 8 89504951 <10-20 0.83 (0.97) 14.83 (10.8) BB 0.141 0.43 (0.0) 0.84 (1.21) BB
1700191 8 112018158 5.03 × 10-11 0.34 (0.08) 4.57 (5.54) BB 3.77 × 10-19 0.81 (0.01) 8.99 (8.93) BB
1746553 8 120342175 1.72 × 10-20 18.45 (14.32) 1.17 (1.43) AA 8.09 × 10-20 10.44 (5.7) 1.19 (0.68) AA
1710029 8 121176983 1.53 × 10-20 19.05 (35.5) 3.30 (1.02) AA 3.61 × 10-20 13.60 (9.1) 2.46 (0.77) NC
1736669 12 41456018 0.843 1.10 (1.08) 0.90 (0.99) NC 0.075 1.68 (1.61) 1.39 (0.03) AA
1693987 17 39301708 1.38 × 10-16 6.20 (10.64) 0.28 (0.28) AA 0.002 0.08 (0.0) 1.06 (0.66) NC
1718017 17 48767363 0.0001 0.93 (0.9) 0.15 (0.0) NC 5.96 × 10-19 6.53 (5.58) 2.04 (1.12) NC
1670177 19 20287003 1.01 × 10-9 0.0 (0.0) 0.03 (0.0) NC 0.310 0.11 (0.36) 1.47 (0.74) NC
Note: WGSA results for 9 SNPs are shown in columns labeled CN_A (copy number of A allele) and CN_B (copy number of B allele). Allelic copy 
number estimates by TaqMan reactions are shown in parentheses. DM Call refers to the genotype call made using the Dynamic Model algorithm 
(DM) using a confidence rank score of 0.05. The VIC reporter dye was measuring the A allele for all SNPs except SNP 1710029 (B allele). The FAM 
reporter dye was measuring the B allele for all SNPs except SNP 1710029 (A allele).BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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between detection power versus false positive rate. In
addition, kernel smoothing across neighboring SNPs can
sacrifice single point resolution. The smoothing window
chosen is 100kb with a Gaussian kernel where the points
near the window boundary has minimum weight, render-
ing an average resolution of no lower than 100kb.
Although this resolution is high compared to traditional
CGH, it is nevertheless sub-optimal compared to the aver-
age of 30kb resolution of single point analysis. These
issues in part should be off-set by new advancements that
allow the resolution of the high density arrays to be fur-
ther increased through a decrease in feature size and
increase in target DNA complexity resulting in the capabil-
ity to simultaneously genotype over 500, 000 SNPs using
a pair of arrays.
Methods
Cell lines & DNA samples
All human breast cancer cell lines (MCF-7, SK-BR-3, and
ZR-75-30) were obtained from American Type Culture
Collection (ATCC). Genomic DNAs were isolated using
QIAGEN QIAmp DNA Blood Mini Kit. DNA samples used
as controls in allelic TaqMan analysis as well as DNA sam-
ples derived from cell lines containing 3X (NA04626), 4X
(NA01416), and 5X (NA06061) chromosomes were pur-
chased from NIGMS Human Genetic Cell Repository,
Coriell Institute for Medical Research (Camden, NJ).
WGSA
The whole genome sampling assay (WGSA) was per-
formed using an earlier version of the final protocol.
Briefly, 250 ng genomic DNA is digested in 20 µl with 10
U of either Xba I or Hind III restriction enzyme (New Eng-
land Biolabs) at 37°C for 2 hr followed by heat inactiva-
tion at 70°C for 20 min. The digested DNA is ligated in 25
µl with 0.25 µM Xba I adaptors (5'-ATTATGAGCAC-
GACAGACGCCTGATCT-3' and 5'-pCTAGAGATCAG-
GCGTCTGTCGTGCTCATAA-3') or Hind III adaptors (5'-
ATTATGAGCACGACAGACGCCTGATCA-3' and 5'-
pAGCTAGATCAGGCGTCTGTCGTGCTCATAA-3') and
250 units T4 DNA ligase (New England Biolabs) at 16°C
for 2 hr followed by heat inactivation at 70°C for 20 min.
DNA amplification is carried out by PCR under the fol-
lowing conditions: each 100 µl reaction contains 25 ng
adapter-ligated genomic DNA, 1 µM primer (5'-ATTAT-
GAGCACGACAGACGCCTGATCT-3'), 300 µM dNTPs, 1
mM MgSO4, 5 U Pfx polymerase (Invitrogen Corporation)
in 1× Pfx Amplification buffer with 1× PCR enhancer (Inv-
itrogen Corporation). Thermal cycling is performed with
94°C for 3 min, followed by 30 cycles of 94°C/30 sec,
60°C/45 sec, 68°C/1 min, and a final extension at 68°C
for 7 min. PCR products are purified and concentrated
with a QIAGEN mini-elute plate and then spectrophoto-
metrically quantitated using absorbance at 260 nm. 40 µg
PCR products are fragmented in 55 µl with 0.2 units
DNase I (Affymetrix) at 37°C for 30 min, followed by
heat inactivation at 95°C for 15 min. The fragmented
DNA products are labeled in 70 µl reactions containing 1×
TdT buffer with 105 units TdT (Promega) and 0.214 mM
DLR (Affymetrix) at 37°C for 2 hr, followed by heat inac-
tivation at 95°C for 15 min. DNA hybridization to the
GeneChip® Human Mapping 50 K Array Xba 240 and
GeneChip® Human Mapping 50 K Array Hind 240, wash-
ing, staining, and scanning were performed exactly as the
manufacturers' instructions (Affymetrix). SNP genotype
calls are made automatically using a likelihood-based
model [60]
Quantitative PCR and TaqMan assays
Quantitative PCR was performed using ABI Prism 7700
Sequence Detection System (ABI). PCR primers were
designed by using Primer Express 1.5 software (ABI) and
were synthesized by Operon Biotechnologies, Inc. Reac-
tions were prepared using the SYBR-Green PCR Core Rea-
gents kit (ABI). 69 autosomal SNPs were selected and
tested. 25 µl reactions containing 25 ng genomic DNA
were set up for each SNP. Normal human genomic DNA
was purchased from Roche Applied Sciences. Conditions
for amplification were as follows: 1 cycle of 50°C for 2
min, followed by 1 cycle of 95°C for 10 min, then fol-
lowed by 35 cycles of 95°C for 20 sec, 56°C for 30 sec,
and 72°C for 30 sec. Threshold cycle numbers were
obtained by using Sequence Detector v1.7a software. For
all 69 SNPs, Roche human genomic DNA was used as the
normal control. All reactions were done in duplicate and
threshold cycle numbers were averaged. DNA amounts
were measured by UV spectrophotometry and were nor-
malized to LINE-1 elements [19]. Relative quantitation
was carried out using the comparative Ct method (ABI
User Bulletin #2, 1997). Quantitative PCR assays for
HER2/NEU were done as described except that the anneal-
ing temperature was 60°C. The primer sequences used for
HER2/neu were (Fw) 5'-GAACTGGTGTATGCAGATTGC-
3' and (Rv) 5'-AGCAAGAGTCCCCATCCTA-3'.
Primers and probes for allelic TaqMan analysis of 9 SNPs
were ordered via the Assays-by-Design Service (ABI). Taq-
Man reactions contained 10 ng genomic DNA in a 25 µl
reaction volume containing 1.25 U of Taq Gold DNA
polymerase, 5 µM MgCl2, 250 µM of dNTPs, 1 µM each of
PCR primer, and both the FAM and VIC labeled TaqMan
probes for the SNP at 0.1 µM final concentration. The
amplification conditions consisted of an initial incuba-
tion step at 95°C for 10 min, followed by 40 cycles at
92°C for 15 sec, 60°C for 1 min using an ABI Prism 7700
sequence detection system. The DNA amounts were nor-
malized to LINE-1 elements. Each SNP was tested with
three normal DNA samples that represented AA, AB, and
BB genotypes. We estimated the allele-specific copy
number with a linear model:BMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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copy number = η0 + η1 × 2∆Ct   (1)
The parameters of such a model (i.e. η0 and η1) were esti-
mated using the three normal samples that represented
AA, AB and BB genotypes; "copy number" is the inherent
two, one, or zero doses of the A allele and zero, one, or
two doses of the B allele of the AA, AB, and BB genotypes
from the corresponding normal samples; "∆Ct" is the Taq-
Man Ct difference between samples. There are in total 18
such models being fit (9 SNPs × 2 alleles per SNP). In gen-
eral this linear framework fits very well with a mean R-
square value of 0.993 and standard deviation of 0.009
across all 18 models. After η0 and η1 have been estimated
for each allele of the nine SNPs, these 18 models are used
to predict copy number from the Ct values associated with
the experimental samples (SK-BR-3 and ZR-75-30).
DNA sequence analysis
PCR primer pairs were designed for a subset of the SNPs.












products were sequenced by dideoxy DNA sequencing
using the individual PCR primers as sequencing primers.
Sequencing chromatograms were visualized using Chro-
mas 2.3.
CNAG and dCHIP
The following samples were used as a reference set during
CNAG [61] analysis: NA17011, NA17101, NA17115,
NA17201, and NA17214. The following samples were
used as a reference set during dCHIP [62] analysis:
NA15029, NA15385, NA15590, NA17011, NA17052,
NA17053, NA17101, NA17115, NA17144, NA17172,
NA17201, NA17214, NA17253, and NA17279. Default
parameter settings are used for both methods.
Data analysis
Intensity transformation and standardization
The basic premise underlying copy number estimation is
that the natural log-transformed chip intensity, following
adjustments on SNP-specific affinity and non-specific
hybridization, is linearly related to the natural log of the
DNA target copy number:
ln(C + δm) = αm,0 + αm,1 (Im - Am) + ε   (2)
where m = 1,....,M is the SNP index, Im is the natural log-
transformed probe intensity on SNP m,  αm,0, which is
always a negative value, represents the quantity to be sub-
tracted due to the SNP-specific optical background, αm,1 is
the scaling factor, δm is the non-specific hybridization, C
is the DNA target concentration (i.e. copy number), Am is
the affinity term determined by probe and target fragment
sequences, and ε is the random noise. The allele specific
copy number estimation (Eq 9 and 10) is based on this
fundamental assumption. The only major difference is the
affinity term Amin Eq 2, which has already been estimated
and regressed out using a quadratic regression model with
probe GC content and fragment length as the predictors
(Eq 5 and 6). To better understand the details of the
method, the main steps of the algorithm are summarized
in a flowchart (Figure 7). The algorithm implements two
rounds of standardization (Eq 3, 7, and 8). The first is
applied on the natural log-transformed raw intensity (Eq
3) and establishes the comparability across samples. The
second is applied prior to the copy number estimation,
and realigns the target intensity according to the mean
from the reference pool (Eq 7 and 8), thereby eliminating
any systematic intensity shift that has not been adjusted
by the previous standardization (Eq 3) or the affinity-
based correction (Eq 5 and 6). This algorithm also
employs a probe selection procedure (Eq 4) following the
first round of standardization in which only probes that
show a strong dosage response across samples (as
DNA sequencing traces surrounding the polymorphic nucle- otide are shown in each panel Figure 6
DNA sequencing traces surrounding the polymorphic nucle-
otide are shown in each panel. The SNP corresponds to the 
underlined base. Panel a and d represent tracings using the 
forward sequencing primer for SNP 1693987. Panels b and e 
represent tracings using the forward sequencing primer for 
SNP 1718017 while panels c and f represent tracings using 
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described in Eq 2) are selected for further analysis. Kernel
smoothing is applied on the estimated copy number at
the level of individual SNPs to further reduce the experi-
mental and technical noise. Regression trees are applied
on the smoothed result to partition each chromosome
into regions with different copy numbers, to assign signif-
icance to each region, and to increase the interpretability
of the overall results. All the parameters in CARAT are
optimized using a training set with 128 individuals. The
training set (Coriell Repositories) consists of 42 African
Americans, 20 Asians, 42 Caucasians and 24 samples
from the polymorphism discovery panel [63]. Among
them, 71 are females and 57 are males. The information
from the training set including the intensity and genotype
are publicly available upon request. Researchers can also
use their own training set for CARAT.
Each SNP on the 100 K array set is represented by 40
unique features (probes): 10 perfect match (PM) probes
and 10 mismatch (MM) probes for both the A and B alle-
les. The natural log-transformation of the raw intensity is
first applied at the probe level for all SNPs. After the trans-
formation, standardization is performed based on MM
probe intensities that best represent background signals.
This achieves a standard Gaussian distribution of the
background intensity to increase the comparability across
chips. For each array with a single DNA sample, back-
ground intensity is defined as the MMa probe intensity for
all SNPs with 'BB' genotype calls and the MMb probe
intensity for all SNPs with 'AA' genotype calls. All PMa
probes are linearly transformed such that under the same
transformation the MMa probes for SNPs with 'BB' geno-
type calls have a variance of one and a mean of zero; all
PMb probes are linearly transformed such that under the
same transformation the MMb probe intensity on SNPs
with 'AA' genotype calls have a variance of one and a
mean of zero.
with  and  the sample estimation under the assumption
In (MMa, lmn | SNPm is autosomal and called genotype BB on
sample l) ~ N (µa,l, σa,l)
with  and  the sample estimation under the assumption
In (MMb, lmn | SNPm is autosomal and called genotype AA on
sample l) ~ N (µb,l, σb,l)
l = 1,..., L is the sample index; m = 1,..., M is the SNP
index; n = 1,..., N is the probe index.  ,  ,  , 
are sample specific parameters; and are subject to change
for any future experiments. Following natural log-trans-
formation and standardization, the 20 PM probe intensi-
ties in conjunction with the genotype information is then
analyzed for copy number information
Probe Selection
PM probes which display a strong dosage response are
selected for use in the algorithm. Each SNP has three pos-
sible genotypes: AA, AB and BB, which each respectively
contains two, one, or zero doses of the A allele and zero,
one, or two doses of the B allele. This provides an inherent
positive control to examine dosage performance at the
individual probe level on a SNP-by-SNP basis. Probe
intensity information from the normal reference set is
compared with genotypic information from the same
individuals. Features with a linear correlation greater than
0.6 between the known allelic dosages based on the gen-
otype calls and the probe intensity are selected. Intensity
across selected probes is averaged and used in subsequent
calculations.
Am = { n | Cor > 0.6 between Sa;rmn and genotype Grm r = 1,...,
R is the reference set}
Bm = { n | Cor > 0.6 between Sb;rmn and genotype Grm r = 1,...,
R is the reference set}
SNPs that do not have at least one selected probe for both
PMa and PMb probe sets were excluded from further anal-
ysis. Am and Bm are parameters determined by the training
set and are fixed for any given training set.
Regression on probe GC content and restriction fragment length
Variation of the SNP intensities can in part be explained
by properties of the probe and restriction fragment
sequences [47,64]. These properties include but are not
limited to the length and GC content of the restriction
fragment target, GC content of the probe sequences, and
secondary structure of the probe and target sequences. An
evaluation of these factors identified the GC content of
the probes and the restriction fragment length as main
contributors to variability in probe intensities using the
100 K WGSA assay. Linear regression, which included lin-
ear and square terms of both variables, was applied to
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Xa,1 is the probe GC content averaged across the selected
PMa probes; Xb,1 is the probe GC content averaged across
the selected PMb probes; and X2 is the restriction fragment
length. The regression coefficients are sample-specific and
thus are re-estimated for each new sample.
The residuals plus the constant term were used as adjusted
intensity in the coming steps with the effects due to the
probes and the fragment being regressed out.
Regression adjustment
Following the standardization and regression on the
probe GC content and the restriction fragment length, a
further correction of systematic intensity deviations was
done by a regression on the reference set mean intensities.
The reference mean intensity for a given probe set (PMa or
PMb) and genotype (AA, AB or BB) was calculated for
each SNP. For a given test sample, two regressions are per-
formed in this adjustment step: one for PMa and one for
PMb. In each regression, the PM intensity on the test sam-
ple across all SNPs is regressed against the average PM
intensity of the reference samples that shares the same
genotype as the test sample. With the estimated regression
coefficients, the test sample is linearly transformed by
subtracting the intercept then dividing by the slope such
that after the transformation, the regression line of the test
SS S S S SS S S al al al al m al M bl bl bl b ,, , , , ,, , ( , ,, ,, ) ; ( , ,, == 12 12 …… …   , ,,
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The CARAT algorithm is summarized as a flow chart, indicating the major steps in both the training set and the test set Figure 7
The CARAT algorithm is summarized as a flow chart, indicating the major steps in both the training set and the test set. "CN" 
refers to copy number. The black dotted line indicates how and where the information from the training set is used in the test 
set.
Training Set (Reference)
Log transform probe 
intensity and 
standardization 
based on MM probes
Probe selection based
on dosage response. 
Compute mean intensity 
across selected probes for
PMa and PMb separately
Intensity adjustment by
regressing on fragment 
length and probe GC 
content  
Summarize mean and variance of 
PMa and PMb intensity 
for each SNP across




at individual SNP level
Use training set intensity to
estimate allele-specific 
and total CN. Summarize 
distribution of total CN of the 
training set at SNP level 
Test Sample
Log transform probe 
intensity and 
standardization 




for  PMa and PMb
Intensity adjustment
by regressing on 
fragment length and 
probe GC content  
Intensity adjustment
by regressing on 
reference mean
Estimate allele-specific
and total CN 
Compare total CN
with the training set 
and derive significance. 
100kb kernel smoothing on
1. allele-specific CN
2. total CN
3. total significance 
Regression tree to 
partition the genome
based on total CN.
Average the CN and
significance in each region
Regression tree to 
further partition each
region based on 
allele-specific CNBMC Bioinformatics 2006, 7:83 http://www.biomedcentral.com/1471-2105/7/83
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sample intensity against the average reference intensity is
Y = X.
Rm,AA = {r | Grm = AA; r = 1, ..., R};   Rm,AB = {r | Grm = AB;
r = 1, ..., R};
Rm,BB = {r | Grm = BB; r = 1, ..., R}; Rm,all = {r | Grm = AA, AB
or BB ; r = 1, ..., R};
Where Rm,AA, Rm,AB, Rm,BB, Rm,all are the corresponding sub-
sets of the reference samples whose genotypes are "AA",
"AB", "BB", and the union of the three groups on SNP m,
(m = 1 to M); Ua,l and Ub,l are two vectors of the average
PMa, PMb intensity across all SNPs on reference samples
that share the same genotype as the target sample l; Glm is
the genotype of test sample l on SNP m;   and 
are the PMa, PMb intensity of reference sample r (r = 1 to
R), SNP m (m = 1 to M);   and   are the PMa, PMb
intensity of test sample l before this adjustment step; and
Ia,l and Ib,l are the PMa, PMb intensity of test sample l after
this adjustment step. The regression coefficients are sam-
ple dependent and thus are estimated for each specific
sample.
Single point copy number prediction and significance calculation
A ln-ln model was used to estimate the copy number of
each allele under the assumption that the natural log of
the DNA target copy number has a linear relationship
with the natural log-transformed intensity, where r =
1,...,R equals the reference set with an assumed diploid
genome.
The parameters in the formulas were estimated using the
reference set and their known genotypes. Ia,rm and Ib,rm are
the PMa, PMb intensity of reference sample r on SNP m;
Ca,rm and Cb,rm are the known copy numbers on the A and
B alleles of reference sample r on SNP m. Since the allelic
copy number can be equal to zero, for each SNP m, two
small positive numbers δa,m and δb,m which represent the
non-specific hybridization that account for the baseline
intensity, were added. The values of δa,m and δb,m were
tested over a range of 0 to 5 with 0.01 increments and the
value which generated the highest linear correlation
between the natural log-transformed copy number ln(Ca,m
+ δa,m) (ln(Cb,m + δb,m)) and the natural log-transformed
chip intensity Ia,m (Ib,m) were selected. SNPs with the high-
est correlation value < 0.8 are removed from further anal-
ysis. After δa,m and δb,m were fixed, The terms that represent
the effect of optical background αa0,m, αb0,m, and the scal-
ing factor αa1,m, αb1,m, were estimated using least square
regression with the normal references as the training set.
After the estimation, the final copy number equation is:
All the parameters involved in the allele-specific copy
number model are fixed with a given training set.
The copy number calculation is allele specific and SNP
specific. The values for the two alleles can be summed to
present the total copy number. The significance of the
total copy number is calculated to identify putative ampli-
fications and deletions. The reference samples are refitted
into the ln-ln linear models and predicted total copy num-
bers are recorded. For a given SNP m, and a given reference
sample r (r = 1 to R), the predicted total copy number is:
For each SNP, there will be a range of variability across the
normal reference samples based on their estimated copy
numbers and such variability is summarized as the refer-
ence distribution under the Gaussian assumption. Target
samples are compared to this reference distribution and
significance is calculated accordingly [35].
For a given test sample l on SNP m, the total copy number
estimate is:
And the significance is calculated as:
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The significance at each SNP tests whether the copy
number value associated with the SNP deviates from the
diploid state.
Define regions with significant alterations
Before defining regions with significant alterations, kernel
smoothing is applied to reduce the effect of outliers
caused by inherent experimental error as well as the occa-
sional true single-marker copy number variant. A band-
width of 100Kb with a Gaussian kernel is applied on the
total copy number, the significance associated with the
total copy number (i.e. log10 transformed p-values), and
the allele-specific copy number. The bandwidth is fixed
for all the analyses. For allele specific copy number,
smoothing is applied separately on the lower copy
number estimate and the higher copy number estimate at
each marker in an effort to present the phased data. In
order to achieve a better estimation, putative regions of
LOH are first identified, defined as more than k (k = 10)
contiguous homozygous calls on the genome; intermit-
tent "no calls" are allowed but not counted in k. In such
regions, all markers, i.e. homozygous calls and no-calls,
participate in the allele-specific smoothing. In all other
regions, only markers with heterozygous genotypes are
used for smoothing to prevent the underestimation of one
strand and the overestimation of the other. In the ideal-
ized case of a perfect copy number prediction on a normal
diploid region of the genome, there will be heterozygous
SNP genotype calls interweaved with homozygous SNP
genotype calls. For heterozygous calls the lower copy
number estimation and the higher copy number estima-
tion of the two alleles will be both close to one. For
homozygous calls, the lower copy number estimation for
one allele will be near zero and the higher copy number
estimation for the other allele will be near two. If both
homozygous calls and heterozygous calls are used for
allele-specific copy number smoothing, then the single
point estimation on the "lower-copy-number" strand will
contain interweaved values close to either zero or one.
After smoothing, the copy number will be lower than one.
Similarly, for the alternate DNA strand, the single point
estimation will contain values close to two or one and the
smoothed values will therefore be higher than one. Thus
using only heterozygous calls in these normal regions
largely reduces such under (over) estimation. In regions
with long stretches of homozygous calls, which rarely
occurs randomly and is more likely caused by asymmetry
between the two strands, it is more appropriate to use all
the markers to do the allele-specific copy number smooth-
ing.
After smoothing, regression trees [45] are applied with the
physical location of each marker as the solo predictor and
the natural-log transformed total copy number plus one
as the outcome (adding one is done to avoid negative
infinity in the case of a homozygous deletion). Log-trans-
formation is used because heuristically the variation in
intensity has been observed to increase with copy
number; and log-transformation stabilizes the variance
and better fits the regression tree framework. The com-
plexity parameter is set to a small value cp = 0.0001 to
ensure that a complex enough partition is tested and to
ensure that splits which do not increase the overall R-
squared value by 0.01% are not tested. In addition,
regions with equal to or less than three points are not fur-
ther split. After a complex enough partition is achieved,
10-fold cross-validation and the one-standard deviation
rule are applied to prune the large tree back to an appro-
priate size to control for over-fitting. After the final parti-
tioning, the average across a region is assigned as the copy
number of that region (it will be a geometric average of
the original copy number estimate since the regression
tree is performed on the log-transformed copy number
space); the significance of that region is the average of the
log10 transformed p-values (deletion uses log10; amplifi-
cation uses -log10). Within each chromosome, regions
with overall non-significant p-values (p-value > 0.01) are
merged with copy number information and the signifi-
cance values are then updated under the assumption that
they represent the same normal diploid state. For allele-
specific copy number estimation, the regression-tree par-
tition is performed in an allele-specific manner and at
each region defined by the total copy number partition.
The results are pruned back using the same cross-valida-
tion approach as was carried out for the total copy
number estimation.
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